Equifax (NYSE:EFX) was upgraded today by Goldman Sachs to buy with a price target of $50 due to improved recent sales.
Shares are higher by nearly four tenths of a percent.
CVS/Caremark (NYSE:CVS) today had its target price increased by Jefferies (NYSE:JEF) to $50, as the firm believes that the vertical integration of CVS Caremark is starting to pay off.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Launch related slideshow:
